Nanotechnology in medicine—known as nanomedicine—has opened a new era for
accurate and precise diagnosis and treatment of pulmonary inflammatory diseases. This …

Nanomedicine is a rapidly emerging interdisciplinary field in which medicine is coupled with
nanotechnology tools and techniques for advanced therapy with the aid of molecular …

Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems
explores the development of novel therapeutics and diagnostics to improve pulmonary …

Nanotechnology provides a broad range of opportunities to develop new solutions for
clinical problems. For the pulmonary field, nanotechnology promises better delivery of drugs …

In both developing and developed nations, pulmonary diseases are the major cause of
mortality and disability. There has been a worldwide increase in the incidence of both acute …

The pulmonary route has recently gained momentum as a suitable avenue for drug delivery.
The large alveolar surface area of approximately 75 m2 coupled with the thin epithelial …

Chronic pulmonary diseases encompass different persistent and lethal diseases, including
chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic …

Pneumonia is a common but serious infectious disease, and is the sixth leading cause for
death. The foreign pathogens such as viruses, fungi, and bacteria establish an inflammation …

Respiratory diseases are an increasing burden for the ageing population. Although our
understanding of these diseases has improved significantly over the past decades …

Nanomedicine is a multidisciplinary research field with an integration of traditional sciences
such as chemistry, physics, biology and materials science. The application of nanomedicine …